Skip to main content

Brain-Specific, Modular and Active RNA Therapeutics

Objective

The overall objective of B-SMART is: 1. to design modular nanoparticles, 2. to manufacture them via a quality-by-design protocol, 3. to achieve delivery of therapeutic RNAs to the brain and treat neurodegenerative diseases.

I. To design modular nanoparticles consisting of
o an active RNA payload
o established (lipid-based), emerging (trigger-responsive polymer-based) or exploratory (extracellular vesicle-based) nanoparticles
o a targeting ligand consisting of the variable domain of heavy chain only antibodies (also known as VHHs or nanobodies), which are coupled to the carrier platform

II. To manufacture the modular nanoparticles using a microfluidic assembly system that will ensure quality-by-design: uniform nanoparticles across research sites and excellent control over the physico-chemical parameters.

III. To test pre-clinical activity of formulations with promising in vitro activity with good cell/blood compatibility and to select the best RNA-formulation for clinical translation to treat neurodegenerative diseases.
Pre-clinical efficacy is tested after
o local injection
o nasal administration
o systemic administration
The neurodegenerative diseases carry a high burden for patients since they are without exception progressive. But they also carry a substantial socio-economic burden with estimated costs of 130 billion euro. per year (2008).

IV. The technical work in B-SMART will be supported by project management. It ensures that the project is coordinated in a clear, unambiguous and mutually acceptable manner and that the project achieves its objectives, within the given financial and time constraints.

in B-SMART we expect to arrive at a scale-able nanoparticle formulation with uniform characteristics that shows strong pre-clinical evidence of therapeutic efficacy and is ready for clinical translation.

Call for proposal

H2020-NMBP-2016-2017

See other projects for this call

Sub call

H2020-NMBP-2016-two-stage

Coordinator

UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Net EU contribution
€ 861 080,00
Address
Heidelberglaan 100
3584 CX Utrecht
Netherlands

See on map

Region
West-Nederland Utrecht Utrecht
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00

Participants (9)

UNIVERSIDAD DE SANTIAGO DE COMPOSTELA
Spain
Net EU contribution
€ 551 375,00
Address
Colexio De San Xerome Praza Do Obradoiro S/n
15782 Santiago De Compostela

See on map

Region
Galicia A Coruña
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
20MED THERAPEUTICS BV
Netherlands
Net EU contribution
€ 398 125,00
Address
Drienerlolaan 5 Kamer Zh252
7522 NB Enschede

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Oost-Nederland Overijssel Twente
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00
VIB VZW
Belgium
Net EU contribution
€ 862 812,50
Address
Rijvisschestraat 120
9052 Zwijnaarde - Gent

See on map

Region
Vlaams Gewest Prov. Oost-Vlaanderen Arr. Gent
Activity type
Research Organisations
Non-EU contribution
€ 0,00
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom
Net EU contribution
€ 889 151,25
Address
Wellington Square University Offices
OX1 2JD Oxford

See on map

Region
South East (England) Berkshire, Buckinghamshire and Oxfordshire Oxfordshire
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI SPA
Italy
Net EU contribution
€ 691 250,00
Address
Via Fossignano 2
04011 Aprilia

See on map

Region
Centro (IT) Lazio Latina
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00
STIFTELSEN SINTEF

Participation ended

Norway
Net EU contribution
€ 88 736,25
Address
Strindveien 4
7034 Trondheim

See on map

Region
Norge Trøndelag Trøndelag
Activity type
Research Organisations
Non-EU contribution
€ 0,00
MALVERN PANALYTICAL LIMITED
United Kingdom
Net EU contribution
€ 571 250,00
Address
Grovewood Road Enigma Business Park
WR14 1XZ Malvern

See on map

Region
West Midlands (England) Herefordshire, Worcestershire and Warwickshire Worcestershire
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH
Germany
Net EU contribution
€ 503 750,00
Address
Heinrich-hertz-allee 1
66386 St Ingbert

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Saarland Saarland Saarpfalz-Kreis
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00
SINTEF AS
Norway
Net EU contribution
€ 580 773,75
Address
Strindvegen 4
7034 Trondheim

See on map

Region
Norge Trøndelag Trøndelag
Activity type
Research Organisations
Non-EU contribution
€ 0,00